Literature DB >> 10197080

The relationship between the growth hormone and insulin-like growth factor axis in long-term survivors of childhood brain tumours.

J C Achermann1, P C Hindmarsh, C G Brook.   

Abstract

OBJECTIVE: We compared IGF-1 and IGFBP3 concentrations in a group of adults treated for brain tumours in childhood with those of matched controls, and investigated the relationship between the GH secretory pattern and IGF-1/IGFBP3 concentrations in the entire group.
DESIGN: We performed 24 h serum GH profiles using 20 minute sampling and measured corresponding fasting concentrations of IGF-1 and IGFBP3. PATIENTS: Fourteen adult male long-term survivors of childhood brain tumours were studied. All had received high dose cranial irradiation (> or = 30Gy; median 12.8 (range 5.8-14.5) years previously). Nine healthy male volunteers acted as controls. MEASUREMENTS: IGF-1 and IGFBP3 concentrations were measured at 06.00 hours. Peak and trough GH activity within the GH profile was analysed by a distribution method which determined the concentration at or below which the serum GH concentration in the profile spent 95% (peak) and 5% (trough) of the total time.
RESULTS: Serum IGF-1 levels were significantly lower in the irradiated group (Irradiated: 200 micrograms/l vs CONTROL: 265 micrograms/l; P = 0.001) but the difference in serum IGFBP3 (Irradiated: 2.3 mg/l vs CONTROLs: 2.77 mg/l; P = 0.03) was less marked. Peak GH activity was lower in the Irradiated subjects (2.59 mU/l vs 9.04 mU/l; P = 0.0004) and correlated strongly with IGF-1 (r = 0.62; P = 0.002) but less so with IGFBP3 (r = 0.35; P = 0.09). This was strenghtened when the range of activity within the profle (peak-trough) was considered. Trough GH activity had a nonsignificant negative correlation with IGF-1 and IGFBP3 levels.
CONCLUSION: The difference in serum IGF-1 concentrations between irradiated subjects and controls was greater than the difference in serum IGFBP3. Peak GH activity and the range of activity within the profile correlated strongly with IGF-1 concentrations but less so with IGFBP3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10197080     DOI: 10.1046/j.1365-2265.1998.00585.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

Review 1.  Radiation-induced hypopituitarism after cancer therapy: who, how and when to test.

Authors:  Ken H Darzy
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-02

Review 2.  Growth Hormone Deficiency and Treatment in Childhood Cancer Survivors.

Authors:  Netanya I Pollock; Laurie E Cohen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-22       Impact factor: 5.555

3.  Factors related to decreased bone mineral density in childhood cancer survivors.

Authors:  Yun Jung Choi; Sun Young Park; Won Kyoung Cho; Jae Wook Lee; Kyoung Soon Cho; So Hyun Park; Seung Hoon Hahn; Min Ho Jung; Nack Gyun Chung; Bin Cho; Byung Kyu Suh; Hack Ki Kim
Journal:  J Korean Med Sci       Date:  2013-10-31       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.